AI Science Tracker
EN

Prediction of 5-year progression-free survival in advanced nasopharyngeal carcinoma with pretreatment PET/CT using multi-modality deep learning-based radiomics.

Fudan University Shanghai Cancer Center · 29 Jul 2022 · medicine

Discovery

Prediction of 5-year progression-free survival in advanced nasopharyngeal carcinoma with pretreatment PET/CT using multi-modality deep learning-based radiomics.

Source check: Source checked. Not independent scientific confirmation.

Finding: The model separated high- and low-risk groups in internal and external cohorts; external cohort comprised 87 patients. External replication and prospective utility were not established in the reviewed material.

Technology: A 3D multimodal deep-radiomics model combined pretreatment PET/CT and clinical stage to estimate five-year PFS.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A 3D multimodal deep-radiomics model combined pretreatment PET/CT and clinical stage to estimate five-year PFS.
Test and result
The model separated high- and low-risk groups in internal and external cohorts; external cohort comprised 87 patients.
Limitation / still unknown
External replication, causal effects and prospective utility were not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.899351/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.